You of course are looking to file with the U.S. FDA for emergency use authorization.
When can we expect that and how soon do you expect that approval.
Thank you. It's a great day for humanity in caring for science. I hope that you will be able to submit all this information
there the day before Thanksgiving and then it's up to FDA to analyze the data and make there. This is great for humanity as
you say great for the markets. We have all our fingers crossed. There's an element here though of course that you can talk with
on 90 governments about about the deals to have this Covid pill. Do you have any revenue estimates as it stands. We know that
Merck which also has a pill under consideration could make five to 7 billion on its Covid pill. Do you have any numbers you
could share. No we don't. Actually I really I didn't even.
And what I'm trying to do here is how many we can make because I understand that this would be a lot of demand for something like
DAX. We had started our investments at 3 risk so we started to prepare for manufacturing. I could approved I said my second
earnings call where it was reliable. I was already more than a billion dollars. So it's a risky investment. Thank God we did
that. So now I think right now we are aligned to have 50 million courses of treatment manufacturing and I'm instructing sites
next year. So it's a significant amount for ISE because it is to 20 appeals from all over the course of treatment or follow or
own drug which is a billion but they're going to manufacture less known genetic products goes together and others. I find it
so significant. So this is my focus right now. And knowing that the results of course from their immediate after I spoke with
our manufacturing people how can we accelerate even further this production. With regards to the manufacturing with regards to
more importantly the distribution of that manufacturing will that be global in scale immediately or will you be going country
by country. We will be global. And right now we are negotiating with all governments and they need to price all of us. Once we
have for others we allocate certain quantities of our expected to manufacture quantities so that everybody will get it in a
fair way. In a fair way. There were also a lot of concerns about the rollout of the Covid-19 vaccines not just from your company
but from the others as well. And about the inequities in the distribution and how to a certain extent that might have
prolonged the Covid crisis. You can't basically inoculate one country without inoculating them all. Yes we are never protected
in a pandemic. Honest your neighbor is protected as well. And I think right now with the Covid vaccines. Let me start. We
thought it would be not a question of a problem of availability for all. As for as a contract would be by the first quarter of
next year. Right now we are aligned to manufacturer Shery Ahn billion doses of which more than a billion.
Almost 40 percent 1.0 will go to middle and low income countries this year. Another than that year this year. And also we have
signed a contract with the U.S. government that we give them a billion doses at cost not for profit for us. So we don't make
money on this. But then they take resources and they give it for free to the poorest countries of the world. The only condition
is they can give it only to the 90 plus poorest countries of the world. So that's the case. But we are also looking also know how
to make sure that we will have equitable distribution and we'll have enough for the poorest countries of the world as well. But
as I said before everybody who wants to receive the same. What are you thinking then about pricing particularly for the
higher income countries to offset lower income countries as well.
You know we are in active negotiations with many governments so I don't want to disclose the price but the prices are same
stimulated with what has been seen in the press for America. And it is less than a half percent sometimes the onset of the crisis
that the antibiotics are costing right now. Are you going to be watching. Don't think cost will be an issue. And keep in mind
that it will be free for all citizens. This is what the government will be charged right. With those negotiations with
the government. Are they following a similar path the way you did with the vaccine. Yes. And they are quite advanced in kind
of shooting out with that. The results are so positive. It would be accelerated in my father. And of course you say this is such
a win for humanity. If we can get it in and across all countries as swiftly as possible. I'm interested in therefore will you
allow generic manufacturing to produce in the poor countries as we've seen with Mark. I am looking at all scenarios and I'm
going to make decisions very quickly. My Michael Barr it is hard to make sure that everybody would get. And you say of course
that at the moment it's about 50 million packs next year. One hundred eighty thousand packs so far at the moment this year. Do
you think that I will be able to be scaled in any way. Yes I think that's good because right now with 60 million bucks we do
know how much market share works and how much demand or product will have. Now I start seeing that it was such a high level of
and with the safety profile. Well actually the demand would be very very very high. There are. So we are going to scale up. All
right. Oh well let's continue down this path here because there are some health care advocates say that I would say in order to
scale up at least at a level that they would want to see that they would actually like to see more participation by other
companies in particular some of the generic drug makers. And they're curious as to whether you're going to be willing to
license out the technology for this particular pill to some of those generic manufacturers to accelerate to scale up. No I
understand very well the question and this is why I answer that I'm looking several options that will allow the poorest
countries together allow everyone to get to this from as possible. And I'm going to make let's say when I was coming here
very soon I'm going to make a final announcement how that will work. But our conversation everybody should get there is another
sort of I guess broader issue out there right now which is the perception that with this pill on the market once it does get
approved if it gets approved that there will be people out there that will say I don't need the vaccine. If I get sick I can just
take this pill. What's the response. That's a good point that's going to making. I think there will
be some people that will say that they are wrong. They're completely wrong. Vaccines are needed. People need to get
vaccinated unless we all get vaccinated. We will all be constantly exposed because we will maintain the form of people
that the virus can replicate and mutate. That's unacceptable. People need to get vaccinated and we need
to conquer our fear so that we can be able and get the protection for ourselves and for the people that we love.
However you know some people will say if those were reluctant knowing that people are dying from God we know that. They know
that that is a field that maybe reduces 90 percent the chances of going to hospital and almost Hang Seng percent. Yeah. Yeah.
Might be a negative point there.